These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31506583)

  • 1. The roles of glucagon-like peptide-2 and the intestinal epithelial insulin-like growth factor-1 receptor in regulating microvillus length.
    Markovic MA; Brubaker PL
    Sci Rep; 2019 Sep; 9(1):13010. PubMed ID: 31506583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for the intestinal epithelial insulin-like growth factor-1 receptor in the intestinal responses to glucagon-like peptide-2 and dietary fat.
    Markovic MA; Srikrishnaraj A; Tsang D; Brubaker PL
    FASEB J; 2020 May; 34(5):6628-6640. PubMed ID: 32212202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function.
    Dong CX; Zhao W; Solomon C; Rowland KJ; Ackerley C; Robine S; Holzenberger M; Gonska T; Brubaker PL
    Endocrinology; 2014 Feb; 155(2):370-9. PubMed ID: 24265452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
    Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
    Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation.
    Fesler Z; Mitova E; Brubaker PL
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32147716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.
    Dubé PE; Rowland KJ; Brubaker PL
    Endocrinology; 2008 Jan; 149(1):291-301. PubMed ID: 17884945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestine.
    Austin K; Imam NA; Pintar JE; Brubaker PL
    Endocrinology; 2015 Feb; 156(2):429-36. PubMed ID: 25514089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartame supplementation in starter accelerates small intestinal epithelial cell cycle and stimulates secretion of glucagon-like peptide-2 in pre-weaned lambs.
    Sun D; Liu L; Mao S; Zhu W; Liu J
    J Anim Physiol Anim Nutr (Berl); 2019 Sep; 103(5):1338-1350. PubMed ID: 31342562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-binding protein-4 inhibits epithelial growth and proliferation in the rodent intestine.
    Austin K; Tsang D; Chalmers JA; Maalouf MF; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G206-G219. PubMed ID: 29631376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.
    Liu X; Murali SG; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1794-802. PubMed ID: 18832087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.
    Murali SG; Brinkman AS; Solverson P; Pun W; Pintar JE; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G794-804. PubMed ID: 22281475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.
    Lee J; Koehler J; Yusta B; Bahrami J; Matthews D; Rafii M; Pencharz PB; Drucker DJ
    Mol Metab; 2017 Mar; 6(3):245-255. PubMed ID: 28271031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 cleavage product GLP-1(9-36) reduces neuroinflammation from stroke via the activation of insulin-like growth factor 1 receptor in astrocytes.
    Huang J; Liu Y; Cheng L; Li J; Zhang T; Zhao G; Zhang H
    Eur J Pharmacol; 2020 Nov; 887():173581. PubMed ID: 32949596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.
    McDonagh SC; Lee J; Izzo A; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G461-8. PubMed ID: 17585017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLP-1 protects β-cells against apoptosis by enhancing the activity of an IGF-2/IGF1-receptor autocrine loop.
    Cornu M; Thorens B
    Islets; 2009; 1(3):280-2. PubMed ID: 21099285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel protective effects of loganin against 1-methyl-4-phenylpyridinium-induced neurotoxicity: Enhancement of neurotrophic signaling, activation of IGF-1R/GLP-1R, and inhibition of RhoA/ROCK pathway.
    Tseng YT; Lin WJ; Chang WH; Lo YC
    Phytother Res; 2019 Mar; 33(3):690-701. PubMed ID: 30556245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
    Dubé PE; Forse CL; Bahrami J; Brubaker PL
    Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion.
    Garrison AP; Dekaney CM; von Allmen DC; Lund PK; Henning SJ; Helmrath MA
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G643-50. PubMed ID: 19118113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7.
    Koehler JA; Baggio LL; Yusta B; Longuet C; Rowland KJ; Cao X; Holland D; Brubaker PL; Drucker DJ
    Cell Metab; 2015 Mar; 21(3):379-91. PubMed ID: 25738454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway.
    Shawe-Taylor M; Kumar JD; Holden W; Dodd S; Varga A; Giger O; Varro A; Dockray GJ
    Peptides; 2017 May; 91():49-57. PubMed ID: 28363795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.